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Purpose: The study was conducted to create a rapidly developing and reproducible animal model of subretinal choroidal
neovascularization (CNV) that allows a time-dependent evaluation of growth dynamics, histopathologic features, and
cytokine expression.
Methods: C57BL/6 and chemoattractant leukocyte protein-2 deficient (∆Ccl-2) mice were studied. Mice received single
or  combined  subretinal  injections  of  cultured  retinal  pigment  epithelium  (RPE;  C57BL/6-derived),  polystyrene
microbeads, or phosphate buffer solution (PBS). Fluorescence angiograms were performed over a period of 3 weeks. Mice
were euthanized on post inoculation day 3, 7, 10, 14, or 21, and their eyes were evaluated by light, confocal, and electron
microscopy.
Results: CNV membranes occurred in all study groups with an overall incidence of 94.3%. They extended in the subretinal
space through central breaks in Bruch’s membrane. CNV lesions were characterized by dynamic changes such as initiation,
active inflammatory, and involution stages. CNV thickness peaked around PI day 7 and was greater in mice that received
combined injections of RPE and microbeads or RPE cells alone. Small lesions developed in the control groups (microbeads
or PBS only), in ∆Ccl-2, and old C57BL/6 mice. Variable expression of cytokines and growth factors was detected within
the membranes.
Conclusions: Our murine model represents a reliable approach inducing CNV growth by subretinal injection of either
RPE cells alone or RPE cells and microbeads. The development of CNV lesions is a dynamic process that relies in  part
on macrophage trafficking and age.
Choroidal  neovascularization  (CNV)  is  a  nonspecific,
stereotypical, ocular wound-healing response to damage of
the  retinal  pigment  epithelium  (RPE)-Bruch’s  membrane-
choroidal complex [1,2]. It has been observed in patients with
age-related macular degeneration (AMD), pathologic myopia,
pseudoxanthoma  elasticum  (Grönblad-Strandberg-
Syndrome),  presumed  ocular  histoplasmosis  (POHS),  and
other subtypes of posterior uveitis, as well as in patients who
have had ocular trauma [1–5]. CNV lesions usually arise from
the choriocapillaris with subsequent extension through breaks
of Bruch’s membrane in the subRPE and subretinal space [1,
2,5–8]. In general, two main CNV growth patterns can been
distinguished:  type  1  growth  pattern  (sub-RPE),  which
involves  CNV  extension  in  the  plane  between  Bruch’s
membrane  and  the  RPE;  and  type  2  growth  pattern
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(subretinal), which is CNV invasion into the subretinal space
between the RPE and the photoreceptor outer segments [1,2,
9,10].
CNV  evolution  is  a  dynamic  process  comprised  of
initiation,  active  inflammatory,  and  inflammatory  inactive
(involutional) phases, comparable to dermal wound healing
[11–13]. It is regulated by a close interaction of various cell
types, cytokines, growth factors, and components of the innate
immune system resulting in a fibrovascular granulation tissue
[8,11,12,14–19].  Morphologic  and  ultrastructural  studies
have shown that the cellular and extracellular components of
CNV  lesions  (i.e.,  RPE,  macrophages,  fibrocytes,  and
vascular endothelium, fibrin) are quite similar, regardless of
the underlying disease [1,2,10,20].
However,  histopathologic  and  immunohistochemical
investigations performed on post-mortem eyes with AMD and
surgically excised CNV specimens have limitations. Post-
mortem eyes usually display late stages of CNV and do not
provide reliable information of early changes occurring in
CNV evolution (initiation and active inflammatory stages)
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146because  of  a  considerable  time-gap  between  onset  of  the
disease and harvest of the tissue [20,21]. Therefore, animal
models of experimental CNV are needed to better investigate
the pathobiology of the lesion in early, mid, and late stages
during CNV formation. Current CNV models are based on
mechanical and transgenic approaches such as enzymatic or
traumatic disruption of the RPE and Bruch’s membrane (i.e.,
laser  photocoagulation)  as  well  as  vector-driven  (e.g.,
matrigel, microspheres, adeno-associated virus) delivery of
pro-  and  anti-angiogenic  cytokines  into  the  vitreous,
subretinal, or suprachoroidal space [22–34]. These models
usually result in small-sized CNV lesions (especially after
laser injury) that primarily extend in the subRPE space (type
I growth pattern) only.
The purpose of this study was to introduce a rapidly
developing and highly reproducible animal (mouse) CNV
model,  which  is  characterized  by  growth  dynamics,
histopathologic,  and  ultrastructural  features  similar  to
subretinal (type II growth pattern) CNV lesions. It is based on
a  traumatic  injury  to  Bruch’s  membrane  secondary  to
subretinal injections of murine RPE cells and polystyrene
microbeads.  RPE  cells  were  used  since  they  are
multifunctional cells involved in CNV formation by secretion
of various cytokines and growth factors. Microbeads on the
other  hand  represent  chemically  inert  particles  that  can
potentially serve as vehicles for delivery of cytokines or anti-
angiogenic agents to the induced membranes. Overall, we
investigated  the  influence  of  RPE  cells,  alone  or  in
combination  with  microbeads,  as  well  as  the  impact  of
impaired  macrophage  recruitment  and  aging  on  CNV
formation.
METHODS
Experimental  animals:  The  study  was  conducted  after
approval of the Institutional Animal Care and Use Committee
of  the  Emory  University.  All  animals  were  treated  in
accordance  with  the  principles  described  in  The  Guiding
Principles in the Care and Use of Animals (NIH), and the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision  Research.  Female  C57BL/6  (stock  #000664)  and
chemoattractant leukocyte protein-2 deficient (∆Ccl-2; stock
#004434)  mice  were  purchased  from  The  Jackson
Laboratories (Bar Harbor, ME). They were either 2-month-
old C57BL/6 and ∆Ccl-2 mice (young), weighing 18–20 g, or
12-month-old  C57BL/6  mice  (old),  weighing  25–30  g.
Weights given are what the mice weighed at the onset of the
study.  ∆Ccl-2  mice  were  used  since  they  demonstrate  an
impaired recruitment of monocytes and macrophages despite
normal  numbers  of  circulating  leukocytes  and  resident
macrophages compared to wild-type mice (i.e., C57BL/6)
[35]. All mice were housed in an institutional animal care
facility in routine polycarbonate cages with free access to food
(regular rodent diet) and water, and maintained with a 12 h:
12 h light-dark cycle.
Experimental design: Mice were divided in 4 study groups
with regard to the subretinal injection technique (RPE cells
only,  RPE  cells  combined  with  microbeads),  genetic
background (C57BL/6, ∆Ccl-2), and age (C57BL/6; 2-month-
old, classified as young, or 12-month-old, categorized as old).
Controls  were  2-month  old  C57BL/6  mice  who  received
subretinal  injections  of  phosphate  buffer  solution  (PBS;
KH2PO4 [0.144 g/l], NaCl [9.0 g/l], and Na2HPO4 [0.795 g/l])
or  polystyrene  microbeads  (Table  1).  Each  group  was
composed  of  25  animals.  Five  mice  per  group  were
sequentially euthanized at post-inoculation (PI) day 3, 7, 10,
TABLE 1. CHARACTERISTICS OF THE STUDY AND CONTROL GROUPS
Mice
Injected
material                   Age                                             Volume
Group Genotype    (month)                 Agent        (µl)                   Concentration
Study group 1 C57BL/6 2 RPE 50 0.5×10
5/µl
Study group 2 C57BL/6 2 RPE+MB 50 0.5×10
5/µl
Study group 3 Ccl-2
−/− 2 RPE+MB 50 0.5×10
5/µl
Study group 4 C57BL/6 12 RPE+MB 50 0.5×10
5/µl
Control group 1 C57BL/6 2 PBS 50 -
Control group 2 C57BL/6 2 MB 50 0.5×10
5/µl
The table summarizes the characteristics of the four study and the two control groups and provides information on the subretinal
injected  agents. The animal groups were composed of 2-month-old C57BL/6 mice (study and control group 1+2), 12-month-
old C57BL/6 mice (study group 4), and 2-month-old Ccl-2 knockout mice (Ccl-2−/−, study group 3). Choroidal neovascularization
membranes were induced by subretinal injection of 50 µl of retinal pigment epithelium (RPE) cells alone or RPE cells and
microbeads (MB) with a concentration of 0.5x105/µl each. The control mice received subretinal injections (50 µl) of phosphate
buffer solution (PBS) or microbeads (0.5x105/µl) Abbreviations: Ccl-2 knockout mice (Ccl-2−/−); RPE represents retinal pigment
epithelium (RPE); microbeads (MB); phosphate buffered solution (PBS); standard deviation (SD).
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14714, and 21. Both eyes were enucleated and evaluated for CNV
growth by light microscopy (right eye; n=5/group), confocal
scanning  laser  microscopy  (left  eye;  n=2/group),  and
transmission and scanning electron microscopy (left eye; n=3/
group).  Fluorescein  angiograms  were  performed  in  single
animals (n=2/group) at PI day 3, 7, 10, 14, and 21.
Microbead  preparation:  Uniform  (4.5  µm)  polystyrene
superparamagnetic microbeads (Dynabeads® M-450 Tosyl
activated;  Dynal  Biotech  LLC.,  Brown  Deer,  WI)  were
prepared as previously described [36]. In detail, microbeads
were  washed  in  0.1  M  phosphate  buffer,  pH  7.4  (2.62  g
NaH2PO4xH2O  [MW137.99],  14.42  g  NaH2PO4x2  H2O8
[MW177.00]),  resuspended  in  phosphate  buffered  saline
(PBS) containing 0.1% (w/v) BSA (BSA Fraction V; Sigma-
Aldrich Corp., St. Louis, MO), and incubated for 18 h at 37 °C
to block the activated tyosyl groups. The microbeads were
then washed twice in PBS containing 0.1% (w/v) BSA, once
in 0.2 M Tris containing 0.1% (w/v) BSA, and stored in PBS
containing 0.1% (w/v) BSA. Prior to injection, the microbeads
were homogenized and a desired volume of microbeads was
transferred to a 1.5 ml test tube and placed in a magnetic rack
(Dynal MPC-Magnetic Particle Concentrator; Dynal Biotech
LLC.) for 1 min. The supernatant was carefully discarded and
the remaining microbeads were resuspended in 1,000 µl PBS
containing 0.1% (w/v) BSA. Each step was repeated 5 times.
Finally, the microbeads were counted and diluted with Hank’s
Balanced  Salt  Solution  (HBSS,  1X;  Invitrogen  Corp.,
Carlsbad,  CA)  to  a  working  concentration  of  0.5x105
microbeads/µl.
Isolation of murine RPE: Murine RPE cells were harvested
from C57BL/6 mice. The freshly enucleated eyes (n=10) were
submerged in 5% Betadine solution® (The Purdue Frederick
Company, Stamford, CT) for 2–3 min, subsequently rinsed in
sterile  HBSS  (2-times),  and  incubated  in  an  enzymatic
solution (pH 8.0) containing HBSS, 19.5 U/ml collagenase,
38 U/ml hyaluronidase, and 0.1% trypsin, at 37 °C for 40 min.
Following  enzymatic  digestion,  sclera  and  choroid  were
dissected from the remaining eye by a circular incision about
1 mm posterior to the limbus. The RPE monolayer was gently
scraped  from  the  retina,  which  remained  attached  to  the
vitreous. The RPE cell suspension was placed in a 50 ml tube
filled with Dulbecco’s Modified Eagle Medium/F-12 RPE
cell culture medium (1X; Gibco, Grand Island, NY), 100 IU/
µl penicillin sodium, 100 µg/ml streptomycin sulfate, 25 µg/
ml  amphotericin  B,  and  5%  (vol/vol)  fetal  bovine  serum
(Sigma-Aldrich Corp., St. Louis, MO). The RPE cells were
centrifuged,  resuspended  in  fresh  RPE  culture  medium,
counted, seeded on 25 cm2 tissue culture flasks, and incubated
at 37 °C in a humidified 5% CO2 atmosphere till grown to
confluence (mean 4 to 6 days). Approximately 105 RPE cells/
eye were routinely obtained. The cells in the flasks were
checked daily for any signs of contamination, and the RPE
growth medium was changed every other day. Once the flask
was covered with an RPE cell monolayer (Figure 1), cells were
trypsinized with 0.05% Trypsin EDTA (1X; Gibco) for 10 to
15 min, centrifuged for 5 min at 200x g, washed 3 times in
HBSS, and counted after staining with trypan blue (staining
of  dead  cells).  Subsequently,  the  RPE  cell  pellet  was
resuspended in HBSS, diluted to a final working concentration
of 0.5x105 cells/µl, and stored on ice. Prior to injection a
desired volume of the RPE cell suspension was mixed with
microbeads at a ratio of 1:1 (0.5x105 cells/μl with 0.5x105
microbeads/μl).
Subretinal injection technique: Injections were performed in
a  similar  fashion  as  previously  described  [36].  Briefly,
animals  were  anesthetized  with  an  intramuscular
administration  of  a  mixture  of  90  mg/kg  ketamine
hydrochloride (Sigma-Aldrich, St. Louis, MO) and 10 mg/kg
Figure 1. Cell culture experiments of retinal pigment epithelium
cells. Retinal pigment epithelium (RPE) cells of C57BL/6 mice were
seeded on tissue culture flasks containing RPE cell culture medium
and cultured for up to 7 days till they were grown to confluence. The
micrographs demonstrate C57BL/6 RPE cells after 3 (A) and 7 (B)
days of cell culture.
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148xylazine hydrochloride (Sigma-Aldrich). Pupils were dilated
with  an  application  of  0.5%  tropicamide,  (Tropicacyl®;
Akorn,  Inc.,  Buffalo  Grove,  IL)  and  0.5%  proparacaine
hydrochloride (Proparacain®; Akorn, Inc.) was applied to each
eye. The eyes were gently proptosed, and a 30 gauge needle
was used to perform a shelving puncture of the sclera at 10
o’clock 1.5 mm posterior to the limbus. A bent 33 gauge blunt
needle  attached  to  a  10  μl  Hamilton  syringe  was  passed
through the sclerotomy in a tangential direction toward the
posterior pole without touching the crystalline lens and placed
on the inner surface of the retina next to the optic disc (Figure
2A). The retina was perforated and 2 µl PBS or RPE cells or
RPE cells and microbeads was injected into the subretinal
space  (Figure  2B).  The  success  of  each  injection  was
confirmed by gently pressing a microscope coverslip on the
cornea,  and  the  fundus  was  evaluated,  using  a  surgical
microscope  (Figure  3),  for  signs  of  retinal  detachment  or
subretinal hemorrhages . Excluded from the study were eyes
that  demonstrated  severe  subretinal  or  intravitreal
hemorrhages (complete hemorrhage of the subretinal bleb or
vitreous  cavity)  and  mice  that  did  not  show  a  retinal
detachment. Topical gentamicin sulfate 0.03% (Akorn Inc.)
were applied to eyes at the end of each procedure.
Fluorescein  angiography:  After  subretinal  injection,
fluorescein angiograms were obtained on days 3, 7, 10, 14,
and 21. Briefly, mice (n=2/group) were anesthetized with
ketamine and xylazine, and the pupils were dilated with 0.5%
tropicamide eye drops. Next, 0.1 ml sodium fluorescein (25%,
Akorn  Inc.)  was  injected  intraperitoneally,  and  serial
angiograms were captured at approximately 3 to 10 min after
dye injection using a Nikon D1 (Nikon, Melville, NY) digital
camera (16X magnifiers, power supply flash 3) attached to a
Zeiss photo-slit-lamp. Vascular leakage was defined as the
Figure 2. Illustration of the subretinal
injection technique. A bent needle was
inserted  through  a  sclerotomy  at  10
o’clock next to the limbus and pushed
forward in a tangential direction toward
the  retina  without  touching  the
crystalline lens (A). Three to 21 days
after  inoculation,  choroidal
neovascularization  membranes
(asterisk)  could  be  identified  in  the
subretinal space next to the optic nerve
by light microscopy (B, C). The retinal
(C)  and  sceral  (D)  insertion  sites  are
highlighted  by  arrows.  B-D:  Periodic
acid-Schiff (PAS) staining was used and
original magnifications are 4X (B) and
20X (C,D).
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149presence of a hyperfluorescent spot that increased in size over
time.
Light  microscopy  and  quantitative  CNV  thickness
measurements: Freshly enucleated eyes (n=5 at each time
point from PI day 3, 7, 10, 14, and 21) were fixed in 10%
buffered formalin for 24 h, dehydrated in a series of graded
alcohols, and embedded in paraffin. Serial sections of 6 μm
thickness were cut and stained with hematoxylin and eosin
according to routine protocols [37]. All tissue sections were
analyzed for the presence of CNV lesions, and the individual
CNV growth pattern (sub-RPE space, subretinal space, or
both) was recorded. For CNV thickness measurements, tissue
sections were masked and evaluated by two observers (I.S.,
L.B.) at 20X magnification using a bright-field microscope
(BHTU; Olympus, Tokyo, Japan). The section with maximal
CNV membrane extension (in regard to height) was identified
Figure 3. Mouse eyes showing retinal detachment after subretinal
injection. Fundus photographs demonstrate circumscribed areas of
retinal  detachment  (asterisks)  following  subretinal  injection  of
retinal  pigment  epithelium  (RPE)  cells  and  microbeads  (A,B).
Occasionally, microbeads (B, arrowhead) and RPE cells could be
observed in the vitreous cavity next to the injection site (A, arrow).
and analyzed. In addition, CNV thickness measurements were
performed on 4 adjacent tissue sections (2 before and 2 behind
the selected section with the maximal CNV extension). The
exact delineation of the CNV lesions was sometimes difficult,
because of intensive pigmentation of the CNV membrane and
the  underlying  choroid.  Therefore,  CNV  thickness  was
estimated indirectly by measuring the distance between the
outer border of the pigmented choroid (next to the sclera) and
the  inner  surface  (adjacent  to  the  photoreceptor  outer
segments) of the CNV (T) and the thickness of the intact
pigmented choroid adjacent to both sites of the CNV (C;
Figure 4) previously described [38,39]. The data from each
group were pooled, and the mean T and C were calculated.
The relative thickness of the CNV membrane was defined as
a ratio of the subtraction (T minus C) over C (mean) (R=[T-
C]/C).
Immunohistochemistry  and  immunofluorescent  studies:
Immunohistochemical and immunofluorescent studies were
performed using one of the following unconjugated primary
antibodies:  1:2,560  anti-CD68  (clone:  KP1;  Dako  Corp.,
Carpinteria,  CA),  1:200  anti-cytokeratin  18  (CK  18,
monoclonal,  MAB3234;  Chemicon  International,  Inc.,
Temecula, CA), 1:1,000 anti-von Willebrand factor (vWF;
polyclonal  rabbit  anti-mouse,  AB7356;  Chemicon
International), 1:200 anti-vascular endothelial growth factor
(VEGF,  polyclonal  goat  anti-mouse,  sc-1836;  Santa  Cruz
Biotechnology,  Inc.,  Santa  Cruz,  CA),  1:200  monocyte
chemoattractant  protein-1  (MCP-1,  polyclonal  goat  anti-
mouse,  sc-1785;  Santa  Cruz),  1:200  matrix
Figure 4. Illustration of the choroidal neovascularization thickness
measurement  technique.  The  photomicrograph  demonstrates  a
representative choroidal neovascularization (CNV) membrane CNV
14 days after subretinal injection of retinal pigment epithelium (RPE)
cells. The distance between the outer surface of the choroid and the
inner surface of the CNV, defined as T, and the distance between the
inner border of the choroid and the RPE monolayer next to the CNV,
defined as C1 and C2, respectively, are indicated by arrows. The
relative  thickness  of  the  CNV  membrane,  defined  as  R,  was
calculated  as  follows:  R=(T-C)/C.  C=(C1+C2)/2.  Original
magnification is 40X.
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150metalloproteinases-2 and −9 (MMP-2, polyclonal goat anti-
mouse, 1:200, sc-8835; MMP-9, polyclonal goat anti-mouse,
sc-6840; Santa Cruz). Briefly, sections were deparaffinized
with  xylene  and  rehydrated  in  graded  ethanol  solutions.
Antigen retrieval using citrate buffer (pH 6.0) was performed
for 5 min at 120 °C followed by cooling for 10 min before
immunostaining. For immunohistochemistry, sections were
exposed to 3.0% hydrogen peroxide for 5 min and incubated
with primary antibodies for 25 min. Binding of the primary
antibodies (anti-vWF, anti-CD68) was assessed by incubation
with 1:30 biotinylated secondary linking mouse- or rabbit-
derived  antibodies  for  25  min,  followed  by  exposure  to
streptavidin enzyme complex for 25 min, diaminobenzidine
as  a  chromogen  for  5  min,  and  counterstained  with
hematoxylin for 1 min. Incubation steps were performed at
room temperature. Between each step, sections were washed
with Tris-buffered saline buffer.
For  immunofluorescence  laser  scanning  microscopy,
sections incubated overnight with following antibodies: anti-
CK  18,  anti-VEGF,  anti-MCP-1,  anti-MMP-2,  and  anti-
MMP-9. The sections were washed and incubated for 1 h with
fluorescein-isocyanate  (FITC)  and  Texas  red-conjugated
secondary antibodies. The sections were then washed 3 times
in  PBS  for  5  min  each,  mounted  with  anti-fade  medium
(Vectashield®;  Vector  Lab.,  Inc.,  Burlingame,  CA),  and
coverslipped. Image acquisition was performed using a laser
scanning confocal microscope (BioRad, Hercules, CA). CNV
containing sections incubated with secondary antibodies only
served as negative controls.
Scanning  and  transmission  electron  microscopy:  For
scanning electron microscopy, eyes were rinsed in HBSS with
subsequent  removal  of  extraocular  tissues  components
including the optic nerve (Figure 5). The eyes were opened
anteriorly  by  8  radial-oriented  corneal  incisions,  which
extended from the center of the cornea to the limbus. The iris
and  lens  were  then  carefully  removed.  The  eye  cup  was
flattened by extending radial relaxing incisions to the equator
until  a  symmetric  “starfish”  appearance  was  achieved.
Finally, the retina was dissected at the ora serrata and gently
separated from the underlying RPE. The remaining eye cups
containing CNV membranes, RPE, choroid, and sclera were
fixed in 2.5% glutaraldehyde, rinsed in 0.1 M cacodylate
buffer,  and  post-fixed  in  1%  osmium  tetroxide.  After
dehydration, the flat-mounted eye cups with adherent CNV
membranes were fixed on specific stubs, sputtered with gold-
pallidium, and examined by scanning electron microscopy
(JEOL 35 CF; JEOL Ltd., Tokyo, Japan) at magnifications
ranging from 2,600X to 6,000X.
For transmission electron microscopy freshly enucleated
eyes  were  fixed  in  2.5%  glutaraldehyde  for  4  h  at  room
temperature. Cornea, iris, and lens were removed, and the
remaining  eye  cups,  including  retina,  CNV,  RPE,
choriocapillaris,  and  sclera  were  washed  with  0.1  M
cacodylate buffer (pH 7.4). CNV membranes were detected
using  a  dissecting  microscope.  A  full  thickness  area,
measuring 2×2 mm and centered on the CNV, was removed
from the remaining eye cup. The dissected tissue block was
post-fixed  in  1%  osmium  tetroxide,  dehydrated  in  graded
ethanol,  and  embedded  in  LX-112.  Serial  thick  sections
(1.5 μm) were cut, stained with 1% toluidine blue in 1% borate
buffer, and subsequently evaluated by light microscopy. The
blocks were trimmed around areas of interest and thin sections
(70–80 nm) were prepared. These were placed in a copper
grid, double-stained with uranyl acetate and lead citrate, and
examined  with  a  JEM-100  CXII  transmission  electron
microscope (JEOL Ltd.) at various magnifications ranging
from 3,500X to 12,000X.
Statistical analysis: Two-way ANOVA was used to compare
the means of CNV thickness among study groups 1 and 2
(C57BL/6; 2-month-old mice; RPE only, RPE+microbeads)
and the two control groups (C57BL/6; 2-month-old mice; PBS
and microbeads only) at 5 time points (Table 2). Overall
TABLE 2. CNV THICKNESS MEASUREMENTS OF THE STUDY AND CONTROL GROUPS
Mice
CNV
Age                incidence
(%/eyes)
CNV thickness (ratio; mean±SD)
Group Genotype     (month)                                       Day 3 Day 7 Day 10 Day 14 Day 21
Study group 1 C57BL/6 2 96/24 4.9±0.6 5.8±1.8 3.3±1.0 2.7±0.5 2.3±0.8
Study group 2 C57BL/6 2 92/23 5.3±1.6 8.6±3.0 7.3±1.8 6.7±1.2 3.5±1.7
Study group 3 Ccl-2−/− 2 96/24 1.7±0.4 3.5±1.3 3.4±0.7 2.4±0.5 1.8±0.6
Study group 4 C57BL/6 12 96/24 2.6±0.4 3.5±0.8 3.5±0.3 2.8±1.3 1.1±0.4
Control group 1 C57BL/6 2 96/24 1.7±0.8 3.0±1.5 2.4±0.8 2.2±0.6 1.3±0.2
Control group 2 C57BL/6 2 88/22 2.0±0.5 2.3±0.5 2.3±0.1 2.5±1.0 2.5±0.5
The table summarizes the results of the choroidal neovascularization (CNV) thickness measurements of the 4 study and 2 control
groups  at post inoculation day 3, 7, 10, 14, and 21. Data are provided as means and standard deviations (±SD). The incidence
of CNV induction was similar in all study and control groups (range 88% to 96%), however, CNV growth was superior in 2-
month-old C57BL/6 mice following subretinal injections of RPE cells (study group 1) or RPE cells and microbeads (study group
2). Abbreviations: Ccl-2 knockout mice (Ccl-2−/−); standard deviation (SD).
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151pairwise comparisons of means among the study and control
groups (study groups 1 and 2, control groups 1 and 2) were
made using Tukey’s multiple comparison procedure. Pairwise
comparisons of means among study groups and controls at
each time point were made using the Bonferroni procedure as
modified by Holm [40]. The same methods were used to
compare means of CNV thickness among young (2-month-
old mice) C57BL/6 and ∆Ccl-2 mice (study groups 2 and 3)
as well as young and aged (2-month-old mice versus 12-
month-old mice) C57BL/6 mice (study groups 2 and 4), which
were injected with RPE and microbeads. ANOVA was used
to determine the relationship (linear, quadratic, etc.) between
the CNV thickness and time in days since the start of the
experiment We found that the variances of CNV thickness
differed among the study groups by themselves and among
the study and control groups; therefore, all analyses were done
using the natural log of CNV thickness. However, means and
standard deviations of CNV thickness are reported in the
original units. All tests were conducted two-sided with a p
value ≤0.05 considered statistically significant. The statistical
calculations were done using the Statistical Analysis System
(SAS, Cary, NC) software.
RESULTS
Fluorescein angiography: Faint fluorescein leakage occurred
at  the  CNV  membranes  up  to  5  min  after  intraperitoneal
injection.  Initially,  fluorescein  angiograms  usually
demonstrated  a  hyperfluorescent  spot  or  ring-like
configuration adjacent to the subretinal injection site. Over
time, fluorescein leakage increased in size and intensity in all
study groups (Figure 6). Fluorescein intensity correlated with
the size of the CNV and was stronger in larger membranes.
Maximum fluorescein leakage was observed around PI days
7  and  10.  Older  lesions  (PI  day  21)  showed  only  faint
fluorescein staining of the CNV with minor changes over time
(data not shown).
Light  microscopic  evaluation  and  quantitative  analysis  of
CNV  membranes:  CNV  lesions  were  detected  by  light
microscopy in the majority of the injected eyes of the 4 study
and  2  control  groups  (Table  2).  CNV  membranes  were
composed of pigmented and non-pigmented spindle-shaped
RPE cells, fibroblasts, and vascular endothelial cells. Mild
accumulation of erythrocytes and inflammatory cells site were
often seen in the early stages after subretinal injection within
the subretinal space around the previous injection (PI day 3;
Figure 7A). All lesions occurred in the subretinal space with
extension  between  the  RPE  and  the  photoreceptor  outer
segments. A central break in Bruch’s membrane was seen in
the  majority  of  the  membranes  (Figure  7A).The  retina
adjacent to the inner surface of the CNV lesion displayed
degenerative changes with partial loss of photoreceptor outer
segments. A uniform distribution of microbeads within the
CNV was observed after combined injection of RPE cells and
microbeads (Figure 7B; main image); microbeads often were
incorporated by adjacent RPE cells. In contrast, eyes that
underwent  subretinal  injections  of  microbeads  only  often
demonstrated separation and accumulation of microbeads at
the inner surface of the CNV lesions (Figure 7B; insert).
Vascularization of CNV membranes could be observed as
Figure  5.  Flat-mount  preparation
technique. Freshly enucleated eyes (A)
were opened by radial corneal incisions
(B). After removal of the iris and lens,
the  radial  relaxing  incisions  were
extended  toward  the  equator,  and  the
eyes  cups  were  flat-mounted  (C).
Choroidal  neovascularization
membranes (arrow) remained attached
to the choroid after gentle removal of the
retina (D)
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152Figure  6.  Fluorescein  angiograms  of  a  subretinal  choroidal
neovascularization membrane. Fundus photographs of a mouse eye
with a choroidal neovascularization membrane (asterisk) 14 days
after  subretinal  injection  of  microbeads.  The  original  subretinal
injection  site  is  indicated  by  arrowheads  (A-C).  Sequential
fluorescein  angiograms  (B,C)  demonstrate  fluorescein  leakage
(white arrows) around the injection site about 120 to 180 s after
intraperitoneal installation of the fluorescein dye.
early as PI day 3 and was present up to PI day 21 (Figure 7C).
Examination of serial sections revealed that the newly formed
blood vessels arose from the choriocapillaris with subsequent
extension into the CNV lesions through the break in Bruch’s
membrane (Figure 7C; main image, inserts). During CNV
evolution, membranes were partially or completely covered
by pigmented RPE cells. These cells appeared to migrate from
the lateral margin of the CNV toward the center of the lesions
(Figure 7D). Histopathologic findings were similar in all study
groups.
CNV  thickness  (relative)  analysis  was  performed  on
serial  sections  through  the  entire  CNV  lesion.  The
measurements are based on the maximal CNV height and the
results  are  summarized  in  Figure  8A-D  and  Table  2.
Quantitative thickness measurements demonstrated dynamic
changes in CNV thickness (R) during CNV evolution, which
were  characterized  by  initiation  and  involutional  stages.
Maximum thickness was observed between PI days 7 and 10
followed by subsequent regression toward PI day 21. For 2-
month-old C57BL/6 mice, the two-way ANOVA showed that
both subretinal injection of RPE cells as well as polystyrene
microbeads (p<0.0001) and day (p=0.0002) were significant
factors; the interaction of these factors was not significant
(p=0.13). Mean CNV thickness was significantly different
among the controls and study groups 1 and 2 (Figure 8A).
Maximum CNV thickness was observed in eyes (C57BL/6)
that  underwent  subretinal  injections  of  RPE  cells  and
microbeads or RPE cells alone (Figure 8A,B). In contrast,
C57BL/6  mice  developed  only  small  lesions  following
subretinal injection of microbeads or PBS.  The  ANOVA
showed that the changes in CNV thickness over time followed
a nonlinear pattern (p=0.0017 for the quadratic term for day).
Among strains of mice treated with RPE and microbeads,
the  two-way  ANOVA  demonstrated  that  both  strain
(p<0.0001) and day (p<0.0001) were significant factors and
that their interaction was not significant (p=0.76). The mean
CNV thickness was significantly different over time between
2-month-old C57BL/6 (young), 2-month-old ∆Ccl-2 mice,
and  12-month-old  C57BL/6  mice  (Figure  8C).  CNV
membranes  in  ∆Ccl-2-  mice,  which  are  characterized  by
impaired recruitment of monocytes and macrophages [33],
showed a dynamic growth pattern similar to age-matched
wild-type  mice  (C57BL/6;  Figure  8C,D).  However,  the
central CNV thickness was statistically smaller compared to
wild-type mice at each PI day, except day 21 (Figure 8D,
Table  2).  No  differences  were  observed  with  regard  to
morphologic  features  between  both  mouse  strains;
quantitative analysis of inflammatory cells within the CNV
lesions (i.e., macrophages) was not performed. Comparison
of CNV thickness measurements between young and aged
C57BL/6 mice demonstrated a reduced CNV size in older
animals, which were statistically significant at PI days 7 and
14 (Figure 8D, Table 2). Older animals revealed maximum
CNV thickness at PI day 7 and minimal CNV central thickness
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153at PI day 21. The ANCOVA found that changes in CNV
thickness over time followed a nonlinear pattern (p<0.0001
for the quadratic term for day).
Immunohistochemistry  and  immunofluorescent  studies:
Antibodies against CK 18, an intermediate filament specific
for the cytoskeleton of normal and reactive RPE cells, were
used to identify and localize RPE cells within the CNV lesions
[36,38,39]. Dual-labeling for CK 18 and one of the following
cytokines  such  as  VEGF,  MMP-2,  MMP-9,  and  MCP-1,
demonstrated  immunoreactivity  of  RPE  cells  within  and
adjacent to CNV lesions in all study groups (Figure 9). RPE-
related cytokines expression was strongest at PI day 3 and 7
and subsequently decreased. Minor cytokine secretion was
observed after PI day 10.
Endothelial cells and macrophages could be detected by
anti-vWF  and  CD68  antibodies,  respectively.  Quantitative
analysis of cytokine expression and macrophage distribution
was not performed.
Scanning and transmission electron microscopic evaluation:
Scanning  electron  microscopy  of  flat-mounted  specimens
Figure 7. Representative hematoxylin and eosin stained cross-sections of subretinal choroidal neovascularization lesions. Membranes extended
into the subretinal space between the retinal pigment epithelium (RPE) monolayer and the photoreceptor outer segments of the neurosensory
retina. Focal damage of Bruch’s membrane and choriocapillaris (asterisk) were present in all lesions (A, image magnification 20X). Subretinal
injections were often accompanied by mild inflammation and choroidal bleeding as shown in representative CNV membrane 3 days after
subretinal injection of RPE cells (A, arrows). Microbeads and RPE cells were usually equally distributed within the CNV membranes (B,
main image magnifaction 40X; PI day 7). In contrast, CNV membranes induced by subretinal injection of microbeads often demonstrated
accumulation of microbeads at the inner surface of the lesion (B, insert magnification 20X; PI day 7). Newly formed blood vessels, which
stained positive for von Willenbrand factor (C, insert bottom right, asterisks, magnification 40X; PI day 10), arose from the choroid and were
present in CNV lesions from PI day 3 thru 21 (C, main image and insert bottom left, arrows, magnification 40X; PI day 3 and PI day 21
respectively). Initially, CNV surface was free of pigmented RPE cells (D, insert bottom left, PI day 3, magnification 10X). Over time (PI day
7 to 10) spindle-shaped RPE cells (arrows) started growing over the CNV membranes (D, insert bottom right, PI day 10, magnification 20X)
and covered the lesions almost completely by PI day 21 (D, main image, PI day 21, magnification 20X).
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154revealed CNV membranes that could be easily identified and
distinguished from the optic nerve head. The lesions were
elevated, with well defined margins, and their shapes were
round to oval (Figure 10A). The CNV surface often revealed
remnants  of  the  adjacent  neurosensory  retina.  High
magnification  images  showed  various  round-  to  spindle-
shaped  nuclei  of  different  sizes  and  photoreceptor  outer
segments  intermixed  with  microbeads  and  erythrocytes
(Figure 10B).
Transmission electron microscopy displayed a variety of
cells within the CNV membranes. The lesions were mainly
composed  of  pigment-laden  RPE  cells,  spindle-shaped
fibroblasts, and vascular endothelial cells. The endothelial
cells were usually flat demonstrating occasional fenestrations.
Microbeads were located either extracellular or intracellular
in RPE cells (Figure 10C,D).
DISCUSSION
CNV development recapitulates a stereotypic wound healing
response  secondary  to  degenerative,  inflammatory,  and
traumatic  alterations  of  the  RPE–Bruch’s  membrane–
choriocapillaris complex [5,21,38,39]. It comprises dynamic
changes,  including  initiation  (cytokine-driven  influx  of
neutrophils  and  macrophages),  stabilization  (angiogenesis
and extracellular matrix formation), and involution/regression
stages  (tissue  remodeling  and  scarring),  resulting  in
granulation tissue formation [14,21,41]. Current experimental
CNV animal models are primarily based on laser-induced
injuries (e.g., argon, krypton, or diode) to Bruch’s membrane
and the choriocapillaris as well as transgenic and surgical
approaches  [22,25,26,29,30,38,42–45].  Although  well
established,  present  experimental  CNV  animal  models  do
have potential limitations. Laser-induced CNV lesions, for
example, are usually small in size and often show a mixed
growth pattern (Type I and II), demonstrating retinal gliosis
and  retinal  neovascularization  [12,14,30].  In  addition,  the
reported incidence of CNV membranes is inconsistent among
different approaches [26,42].
The purpose of our study was to develop a reliable and
reproducible  CNV  animal  model  easily  monitored  by
fluorescein  angiography  and  histopathology  examination.
The described CNV model is based on subretinal injections
of RPE cells and chemically inert microbeads. However, the
high incidence of CNV lesions even in the control groups
(subretinal injections of PBS and microbeads only) indicates
that a mechanical trauma to Bruch’s membrane secondary to
subretinal injections seems to be the predominant factor for
the CNV lesions to develop. Our findings are in accordance
with  previous  observations  that  propose  a  compromised
structural barrier between retina and choriocapillaris, even in
absence of a mechanical trauma (i.e., secondary to chronic
inflammation  with  upregulation  of  metalloproteinases)  as
mandatory for CNV formation [22,28,34,42,46–49]. Overall,
subretinal injections of RPE cells, alone or in combination
with microbeads, proved to be efficient and highly reliable for
subretinal CNV formation with an overall incidence ranged
between 88%–96%, comparable to previous investigations
(54–100%) [30,31,42,50]. CNV lesions were characterized by
fluorescein leakage and dynamic changes including initiation
Figure 8. Growth dynamics of choroidal
neovascularization  membranes
following subretinal injection. Line and
bar graphs (A-D) display changes in the
thickness  of  choroidal
neovascularization  (CNV)  membranes
at post inoculation (PI) day 3, 7, 10, 14,
and  21.  CNV  formation  was  more
pronounced  in  eyes  following  retinal
pigment  epithelium  (RPE)  cells  and
microbeads with maximal extension at
PI  day  7  (A,B).  CNV  lesions  were
thicker in 2-month-old C57BL/6 mice
compared  to  age-matched  Ccl-2-
deficient  and  aged  12-month-old
C57BL/6 mice (C,D). Bars represent the
means  (n=5  eyes/group)  at  each  time
point (PI day 3, 7, 10, 14, and 21); error
bars  represent  standard deviation (SD).
The asterisk indicates p<0.05.
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155Figure 9. Confocal laser scanning microscopy on choroidal neovascularization membranes. Images display choroidal neovascularization
(CNV) membranes of 2-month old C57BL/6 mice after subretinal injection of retinal pigment epithelium (RPE) cells and microbeads. Tissues
section with CNV lesions were stained with antibodies against various cytokines and cytokeratin (CK) 18 (left column) secondary Abs only;
middle is with antibody to cytokine only; right shows merged image. Cytokine expression revealed a time-dependent release of vascular
endothelial growth factor (VEGF; A-C: post inoculation [PI] day 3), matrix metalloproteinases (MMP)-2 (D-F: PI day 7), MMP-9 (G-I; PI
day 10), and monocyte chemoattractant protein (MCP)-1 (J-L; PI day 14) by CK 18-positive RPE cells.
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156as well as active inflammatory and regression stages [10,21,
38].
RPE  cells  were  used  since  they  represent  the  most
common cellular component of CNV lesions and have been
shown to play a pivotal role in intraocular inflammation and
ocular wound healing such as CNV formation [9,15,16,18,
38,51–53]. Once stimulated, RPE cells transdifferentiate into
a wound-healing phenotype, releasing pro-inflammatory and
angiogenic  cytokines  (i.e.,  VEGF,  MCP-1,  MMP-2,  and
MMP-9) in a time-dependent fashion as demonstrated in our
model  and  previous  models  [21,33,51,52,54].  In  addition,
RPE cells have been shown to synthesize different proteins
and receptors of the complement system that are involved in
CNV formation [16–18]. Microbeads on the other hand are
biologically  inert,  nondegradable  vehicles  designed  for
immunomagnetic  cell  separation  and  protein  purification.
Like microspheres and sepharose beads, they can be labeled
with antibodies and small molecules (i.e., growth factors,
cytokines)  with  subsequent  delivery  to  different  ocular
compartments [23,31,55].
In comparison, combined injections of RPE cells and
microbeads were most efficient in inducing CNV lesions.
Differences in CNV extension of eyes injected with RPE cells
only and those which received RPE cells and microbeads
might  in  part  be  explained  by  prolonged  and  increased
cytokine expression secondary to microbead-induced RPE
cell separation [56,57]. RPE cell culture models have shown
that  regenerative  mechanisms,  such  as  proliferation  and
transdifferentiation, of RPE cells are facilitated by close cell-
cell  interactions  and  inversely  correlated  to  cell  contact
inhibition [56,58]. Morphologic and ultrastructural evaluation
of the induced CNV lesions showed no differences among the
Figure 10. Scanning and transmission electron microscopic images of choroidal neovascularization membranes. Choroidal neovascularization
(CNV) membranes (A, arrow) were partially covered by remaining photoreceptor cells after removal of the retina. Occasional microbeads
(B, arrowheads) and doughnut-shaped erythrocytes are present at the inner CNV surface (B, arrows). CNV membranes were composed of
fibroblasts, pigmented retinal pigment epithelial (RPE) cells, and non-pigmented RPE cells; a well structured surface was missing (C, arrows).
The  RPE  monolayer  (C,  arrowheads)  and  photoreceptor  outer  segments  (asterisks)  next  to  the  CNV  margin  appeared  normal.  High
magnification images of the CNV lesions revealed pigment-laden RPE cells with intracytoplasmatic microbeads (black asterisks), spindle-
shaped fibroblast (arrowheads), endothelial cells (arrow), and erythrocytes (white asterisk) within small-sized blood vessels (D).
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157individual groups. CNV membranes were mainly composed
of RPE cells, fibroblasts, and endothelial lined blood vessels
and displayed increased fibrosis and reduced cellularity with
aging [2,14]. The newly formed blood vessels originated from
the  choriocapillaris,  although  a  contribution  of  the  retinal
vasculature as described in transgenic and laser-induced CNV
models could not be excluded [27,28].
To further confirm our model, we also examined the
effect  of  impaired  macrophage  trafficking  (∆Ccl-2  versus
C57BL/6 mice) and aging (12-month-old versus 2-month old
C57BL/6 mice) in CNV evolution as previously performed
[49,59–62]. Similar to RPE cells, macrophages are common
CNV cell types and are able to promote CNV formation by
expressing  chemotactic,  angiogenic,  and  proteolytic
cytokines (i.e., tumor necrosis factor [TNF]-α, TGF-β, and
VEGF) [5,9,12,38,61,63,64]. Macrophage recruitment to the
site of inflammation is triggered by different chemotactic
factors,  such  as  MCP-1  (Ccl-2),  a  member  of  the  C-C
chemokine super family, which is secreted by RPE cells,
astrocytes,  fibroblasts,  and  endothelial  cells  [9,65–68].  A
close  interaction  of  MCP-1  and  macrophages  in  CNV
formation  could  be  confirmed  in  our  model  that  showed
significantly smaller CNV lesions in Ccl-2 deficient mice
compared to age-matched C57BL/6 mice. Similar results have
been previously reported after systemic macrophage depletion
[9,38,60,68,69]. That CNV lesions were still able to develop
in  MCP-1  knockout  mice  might  be  explained  by  co-
expression of other monocytes attractant chemokines such as
macrophage inflammatory protein-1α and −1β and RANTES
(regulated on activation, normal T expressed and secreted)
[41,62,70,71]. Resident macrophages and inflammatory cells
such as neutrophils, lymphocytes, and natural killer cells, also
demonstrate  angiogenic  capacity  and  thereby  partially
contribute to CNV formation [61,65,68,72].
Compared to Ccl-2-deficient mice, we also found smaller
lesions  in  12-month-old  wild-type  (C57BL/6)  mice.  In
contrast  to  2-month-old  C57BL/6  mice,  lesions  were
significantly  smaller  in  thickness,  revealing  impaired
angiogenesis and neovascularization in older animals [73,
74]. Our data might in part be explained by an age-related
delayed and impaired wound healing response with a reduced
expression of chemokines and angiogenic factors [59,60,73–
75]. Aging animals are usually characterized by a deteriorated
immune system exemplified by an imbalance of pro-and anti-
inflammatory mediators and detrimental effects on specific
cellular components of the innate immune response [76]. In
addition,  aged  macrophages  and  endothelial  cells  are
functionally  compromised,  resulting  in  an  impaired
phagocytotic and proliferative capacity [75,77,78].
In summary, our experimental animal model represents a
reliable  and  reproducible  approach  to  initiate  CNV  by
subretinal  injection  of  RPE  cells  in  combination  with
microbeads.  CNV  formation  can  easily  be  visualized  by
fluorescein  angiography,  light  microscopy,  and  electron
microscopy. Our model is applicable to various murine strains
and might be used to study the effect of novel anti-angiogenic
treatments  by  labeling  those  agents  with  microbeads.
Although microsurgical skills and some initial training are
required to obtain consistent results, our model appears to be
less  complicated  in  comparison  to  previous  models  as  it
eliminates  the  need  for  vitreoretinal  surgery  including
vitrectomy [22,30,34]. The success rate of producing CNV is
comparable to similar experimental CNV animal models [30,
31,42,44,47,79,80]. Limitations of our current study include
the  small  sample  size  and  the  short  follow-up  period.  In
addition, a direct correlation to CNV formation in humans is
not  possible  since  our  mouse  model  is  a  trauma  model.
Modifications  (i.e.,  labeling  of  microbeads  with  pro-
angiogenic factors) as demonstrated in other studies might be
of interest to further improve our model and to develop longer-
lasting CNV lesions [23,31,44].
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